New drug puts malaria under the pump

New drug puts malaria under the pump
Credit: John Tann

Researchers have discovered how a new class of antimalarial drugs kills the malaria parasite, showing that the drugs block a pump at the parasite surface, causing it to fill with salt.

In work conducted at the Research School of (RSB) at The Australian National University (ANU), and published in the latest edition of Cell Host & Microbe, Dr Natalie Spillman showed that the malaria parasite has at its surface a protein that serves as a molecular salt pump, pushing sodium ions out of the parasite.

"It was within a week or two of our identification of the pump protein that a paper came out reporting the discovery of the spiroindolone antimalarials," Dr Spillman said.

"The authors of the spiroindolone study identified the pump protein as being of particular interest from the point of view of how the spiroindolones might work, but the exact mechanism was a mystery.

Linking up with members of the spiroindolone-development team in Singapore (Novartis Institutes for Tropical Diseases) and the US (Genomics Institute of the Novartis Research Foundation), Dr Spillman showed that spiroindolones block the parasite's salt pump, causing the cell to fill rapidly with salt.

"We believe the spiroindolones kill the parasite by causing a salt overload," Dr Spillman said.

RSB Director Professor Kiaran Kirk, the senior author on the study, says this vulnerability in the parasite's physiology can be exploited to develop much needed new .

"The malaria parasite's salt pump would seem to be an Achilles heel for the parasite, particularly vulnerable to attack. Knowing this, we can now look for other drugs that block this pump. We can also start to investigate how the parasite might be able to change the shape of the pump and thereby develop resistance to this class of drugs. Both of these aspects are going to be very important in our ongoing battle with the parasite."

The spiroindolones are the first genuinely novel class of chemicals to be tested in malaria patients for over 20 years.

"We desperately need new antimalarials and the spiroindolones, now in advanced clinical trials, are looking extremely promising," Professor Kirk said.

"Understanding how these compounds kill the parasite gives us a tremendous advantage."

The is a single-celled organism that invades the red blood cells of its human host, killing more than a million people each year. It is becoming increasingly resistant to most of the antimalarial drugs that are currently in use.

Related Stories

New opportunity for rapid treatment of malaria

date Oct 25, 2012

(Medical Xpress)—Researchers have identified a new means to eradicate malaria infections by rapidly killing the blood-borne Plasmodium parasites that cause the disease.

Recommended for you

Why you need one vaccine for measles and many for the flu

date 19 hours ago

While the influenza virus mutates constantly and requires a yearly shot that offers a certain percentage of protection, old reliable measles needs only a two-dose vaccine during childhood for lifelong immunity. ...

Scientists turn blood into neural cells

date 19 hours ago

Scientists at McMaster University have discovered how to make adult sensory neurons from human patients simply by having them roll up their sleeve and providing a blood sample.

How our gut changes across the life course

date 21 hours ago

Scientists and clinicians on the Norwich Research Park have carried out the first detailed study of how our intestinal tract changes as we age, and how this determines our overall health.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.